Johnson Fistel, PLLP is investigating whether Wave Life Sciences Ltd. or its executives violated federal securities laws following a sharp stock decline after the company reported interim Phase 1 clinical trial results. The trial data showed modest fat and weight reductions, but the stock drop caused investor losses. The law firm is encouraging affected investors to join the investigation to potentially recover losses. This probe could lead to legal action if violations are found.
India's military Electro-Optical/Infrared (EO/IR) market is projected to grow to $1.78 billion by 2030 at an 8.9% CAGR, fueled by rising geopolitical tensions and increased border surveillance needs. The market growth is supported by AI integration, ...
Infineon Technologies has partnered with NVIDIA to support the MGX AI Factory ecosystem, focusing on transforming power delivery for advanced AI data centers. Infineon's power management solutions will enable efficient power conversion within NVIDIA'...
Mission Produce has finalized its acquisition of Calavo Growers, creating a stronger, vertically integrated fresh produce company with an expanded footprint in North America. This merger combines two leading avocado providers, enhancing sourcing, pac...
Innovent Biologics has entered a $10.5 billion partnership with Pfizer to co-develop and co-commercialize a portfolio of 12 early-stage cancer medicines, focusing on antibody-drug conjugates. Innovent will share costs and profits with Pfizer in the U...
Bitcoin fell to a six-week low of around $72,728, down 3.2% on the day and 5% for the week, as broader market weakness pressured prices. Large investors, or whales, especially in derivatives, have been repositioning to manage liquidation risks, with ...
